Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.7 DKK | +1.71% | -1.33% | +8.20% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 869M 6.04B | Sales 2025 * | 945M 6.57B | Capitalization | 1.79B 12.41B |
---|---|---|---|---|---|
Net income 2024 * | 72M 501M | Net income 2025 * | 86M 598M | EV / Sales 2024 * | 2.53 x |
Net Debt 2024 * | 412M 2.86B | Net Debt 2025 * | 383M 2.66B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
23.7
x | P/E ratio 2025 * |
19.9
x | Employees | 4,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.4% |
Latest transcript on Embla Medical hf.
1 day | +0.34% | ||
1 week | -1.33% | ||
Current month | -11.34% | ||
1 month | -8.90% | ||
3 months | +4.58% | ||
6 months | +15.12% | ||
Current year | +8.20% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 29.7 | +1.71% | 7 105 |
24-04-26 | 29.2 | 0.00% | 27,150 |
24-04-25 | 29.2 | -5.19% | 13,134 |
24-04-24 | 30.8 | +0.33% | 76,638 |
24-04-23 | 30.7 | +1.99% | 68,158 |
Delayed Quote Nasdaq Copenhagen, April 29, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.20% | 1.79B | |
+2.36% | 24.07B | |
-5.87% | 16.75B | |
+8.42% | 13.7B | |
-15.85% | 2.06B | |
+40.94% | 1.73B | |
+11.40% | 589M | |
0.00% | 400M | |
+29.45% | 135M | |
+27.49% | 93.49M |
- Stock Market
- Equities
- EMBLA Stock